A multidisciplinary and talented team from Sylvester Comprehensive Cancer Center presented a project called “Letting Go” of Denied Charges to Build a Lean Healthcare System at the 26th Annual Florida Sterling Conference, took home the top team prize, and patients are benefiting from their work. The 12-minute presentation included a song-and-dance performance with a Frozen theme.
Chemotherapy can extend life, or even provide a cure, but occasionally with side effects so severe that patients reduce or discontinue treatment. Take the case of paclitaxel, an agent originally derived from the bark of the western yew tree, and one of the most common tools used to treat cancers of the ovary, breast, lung, and head and neck.
Researchers at Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine have shown that inhibiting the enzyme CARM1 (also called PRMT4) dramatically slows acute myeloid leukemia (AML) progression but does not affect normal blood production. This selectivity could make it an ideal drug target for AML – a disease with few treatment options. The study was published online June 11 in Cancer Cell.
For nearly 60 years, the Woman’s Cancer Association of the University of Miami has supported cancer research, education and patients’ needs. On June 7, the WCA was honored in a ribbon-cutting ceremony at Sylvester Comprehensive Cancer Center at The Lennar Foundation Medical Center. This special celebration marked the dedication of a patient lounge on the fourth floor that now bears the group’s name.
Journalists from Japan, Portugal and other countries lined up to interview Sylvester Comprehensive Cancer Center’s associate director of global oncology, Gilberto Lopes, M.D., MBA, outside the press room at the annual meeting of the American Society of Clinical Oncology. It was June 3, and as lead author of the Keynote-042 study, Lopes had just released the impressive results of an immunotherapy drug for lung cancer patients.
The director of Sylvester Comprehensive Cancer Center’s Braman Family Breast Cancer Institute at Plantation, Alejandra Perez, M.D., has been appointed to serve on the Clinical Practice Guidelines Committee of the American Society of Clinical Oncology. ASCO is the world’s leading professional organization for physicians and oncology professionals caring for people with cancer.
On June 4, The New England Journal of Medicine published an update to a large, international study of two clinical trials that examined the comparative survival rates for adjuvant therapies for hormone-receptor-positive breast cancer in premenopausal women. The journal’s editors turned to Marc E. Lippman, M.D., a breast cancer specialist at Sylvester Comprehensive Cancer Center, to write an accompanying editorial.
Over the Memorial Day weekend, clinician-scientists from Sylvester Comprehensive Cancer Center’s expanding state-funded Firefighter Cancer Initiative met with firefighters and paramedics at fire rescue departments throughout the greater Jacksonville area, and presented an overview of their research and cancer screening projects.
Patients at Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine are the first in the country to receive new specially designed hoodies donated by Oscar de la Renta, LLC. In place of a long zipper down the middle, these hoodies have two shorter diagonal zippers that make it easier for nurses to access chemotherapy chest ports, while helping patients stay warm.
Sylvester Comprehensive Cancer Center will be well represented at the 2018 American Society of Clinical Oncology (ASCO) meeting June 1- 5 in Chicago, as several physicians and researchers are scheduled to make key presentations. At the Plenary Session on Sunday, June 3, Gilberto Lopes, M.D., M.B.A., associate director of Global Oncology at Sylvester, will present the abstract on the Phase III KEYNOTE-42 study.